Huntington Bancshares Incorporated Reports 2026 Third-Quarter Earnings

Huntington reported Q3 2026 revenue of $2.791 billion, up from $2.134 billion a year earlier, and net income of $680 million versus $602 million; diluted EPS fell to $0.33 from $0.41. Compared with Q2, revenue and net income were slightly lower, while the net charge-off ratio rose to 0.31% from 0.25%. CEO Steve Steinour said the bank was achieving targeted cost and revenue synergies from recent partnerships and remained on track to meet its financial targets.

Analysis

The constructive signal is improving spread economics: NIM and NII edged higher sequentially, while expenses eased. But this did not translate into sequential revenue or PPNR growth, and the year-over-year balance-sheet comparison is affected by the Veritex and Cadence additions; do not treat it as organic momentum without acquired-vs-organic disclosures. The more consequential risk is credit: higher NCO and NPA ratios alongside a lower ACL ratio warrant attention to criticized/classified loans, CRE exposure, and reserve coverage—not just headline earnings. The slight sequential decline in tangible book value and lower TCE ratio also limit the quality of the capital story, despite the modest CET1 improvement.

Near term, the conference call is the catalyst: management’s bridge for fee-income weakness, deposit pricing, acquired-business synergies, and credit migration should determine whether this is benign noise or an earnings-quality issue. Over 1–3 months, watch reported organic loan/deposit trends and provisions; over 6–18 months, integration execution and regional-bank credit losses matter more than modest NIM expansion. The release alone does not establish valuation or market expectations, so conviction for an outright directional trade is limited. The contrarian risk is that investors focus on the NIM improvement and synergy narrative while underweighting credit deterioration and the difficulty of converting cost actions into revenue growth.

Key Decisions for Investors

• Do not chase HBAN on the NIM improvement alone. On today’s call, verify organic versus acquired loan growth, deposit beta/funding costs, fee-income drivers, and a quantified synergy timetable before adding exposure.
• Conditional relative-value hedge: if management signals worsening criticized loans, higher expected provisions, or delayed synergies, short HBAN against a diversified regional-bank ETF such as KRE; close or avoid the hedge if credit metrics stabilize and organic PPNR growth resumes. No price target is justified by the supplied data.
• For existing holders, monitor NCOs, NPAs, ACL coverage, and tangible capital over the next 1–3 quarters. A further deterioration in credit indicators or a material guidance reset would falsify the benign-integration thesis; stable credit and sustained expense discipline would weaken the cautious view.